Telix Pharmaceuticals Limited

A$13.67As of Sun 8 Nov 2026, 12:00 UTC
ASX:TLXHealthcare
Country Australia
PE (Fwd) •••
TSR 9Y CAGR 40.66%
Div yield —
ROE 7.37%
Biotechnology
Beta (5Y) 0.63
PE TTM 99.14
TSR TTM (14.99%)
Mkt cap A$4.645B
ROIC 6.78%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
24.21%
(5.12%)
Hold 2|4|1|1|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.16
0.17
0.18
11.24%
15.34%
14.89%
12.82%
Revenue$M
218.1
224.0
224.0
223.1
7.44%
8.29%
2.27%
1.28%
Peers (US$3.190B)
Cap (US$)
PE
1.810B
—
Capital
TTM
5Y
10Y
Leveragex
0.842
(1.172)
(0.995)
EBIT/Intx
1.441
0.119
0.126
Own earn%
153.64
(8.09)
(12.40)
Sh yield%
9.20
38.73
38.88
Owners
Insiders/Inst%
7.58
83.05
Short interest%
1.17
SBC / revenue%
4.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
18–24
$1 testx
0.0
Incr. ROIC%
1